Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia. (Record no. 24285557)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02270 a2200685 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517000416.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201506s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1476-5551 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1038/leu.2014.305 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Sandhöfer, N |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20150604 |
245 00 - TITLE STATEMENT | |
Title | Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Leukemia |
Date of publication, distribution, etc. | Apr 2015 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 828-38 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Animals |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Apoptosis |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Synergism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gene Expression Regulation, Leukemic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gene Rearrangement |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Heterocyclic Compounds, 3-Ring |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Imidazoles |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Leukemia, Myeloid, Acute |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Myeloid-Lymphoid Leukemia Protein |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Oncogene Proteins, Fusion |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Phosphatidylinositol 3-Kinases |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Phosphoinositide-3 Kinase Inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Proto-Oncogene Proteins c-akt |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Quinolines |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Signal Transduction |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sirolimus |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Survival Analysis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | TOR Serine-Threonine Kinases |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Tumor Burden |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Xenograft Model Antitumor Assays |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Metzeler, K H |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rothenberg, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Herold, T |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tiedt, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Groiß, V |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Carlet, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Walter, G |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hinrichsen, T |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wachter, O |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Grunert, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Schneider, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Subklewe, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Dufour, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fröhling, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Klein, H-G |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hiddemann, W |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jeremias, I |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Spiekermann, K |
773 0# - HOST ITEM ENTRY | |
Title | Leukemia |
Related parts | vol. 29 |
-- | no. 4 |
-- | p. 828-38 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1038/leu.2014.305">https://doi.org/10.1038/leu.2014.305</a> |
Public note | Available from publisher's website |
No items available.